论文部分内容阅读
患者,女性,49岁,2012年12月初无明显诱因下触及左侧乳房肿块一枚就诊,体检:左乳外上象限可触及一大小约5cm×4cm×3cm肿块,质硬,可推动,边界尚可,轻度压痛,无表面皮肤红肿发热,无溃烂,无皮肤内凹,无橘皮样改变,无乳头溢液。B超提示左侧乳腺内实质性占位病变,诊断为左乳肿块。2012年12月7日在全麻下行左侧乳癌改良根治术,术中见左乳外上象限肿块约3cm×2cm大小,质硬,表面欠光滑。快速病理提示:左乳浸润性癌。术后病理:(左乳)见导管内小细胞癌残留,乳头、基底未见癌累及,淋巴结见癌转移(2/13)。免疫病理提示:(左乳)小细胞癌。癌细胞神经黏附分子糖蛋白(SCLC)、神经烯醇化酶(NSE)、CD99、CD56
Patients, female, 49 years old, with no significant incentive to touch a breast mass on the left side at the beginning of December 2012. Physical examination: The left breast upper quadrant can reach a size of approximately 5cm x 4cm x 3cm mass, hard and pushable, border Yes, mild tenderness, no skin irritation and fever on the surface, no ulceration, no skin concave, no change of orange peel, no nipple discharge. B-ultrasound showed a substantial mass lesion in the left breast and was diagnosed as a left breast mass. On December 7, 2012, the modified radical mastectomy was performed on the left side of the breast cancer under general anesthesia. The size of the left breast quadrant of the left breast was approximately 3cm x 2cm in size. It was hard and the surface was less smooth. Rapid pathology: left invasive breast cancer. Postoperative pathology: (left breast) showed residual small cell carcinoma in the duct, no involvement of the papilla and basal ganglia, lymph node metastasis (2/13). Immunopathology: (left breast) small cell carcinoma. Cancer cell neural adhesion molecule glycoprotein (SCLC), neuroenolase (NSE), CD99, CD56